Close Menu

Science 'Threatened'

Researchers in Europe are holding their collective breath as a European court tries to decide whether to ban patents on technologies that use human embryonic stem cells, says Veronique Greenwood at the 80beats blog. Scientists warn that if this ban is imposed and labs can no longer make money from their discoveries, regenerative medicine will not go further than the bench, she adds.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.